Parity and pancreatic cancer risk: A dose-response meta-analysis of epidemiologic studies

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Guan, Hong Bo ^a   Wu, Lang ^b   Wu, Qi Jun ^c,d   Zhu, Jingjing ^e   Gong, Tingting ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b MAYO CLINIC   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d School of Medicine   (China)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; CORRELATION ANALYSIS; HUMAN; LIVE BIRTH; PANCREAS CANCER; PARITY; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SMOKING; SYSTEMATIC REVIEW;

CASE-CONTROL STUDIES; FEMALE; HUMANS; ODDS RATIO; PANCREATIC NEOPLASMS; PARITY; PREGNANCY; PROSPECTIVE STUDIES; RISK;

EID: 84899098744     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092738     Document Type: Article

References (65)

1. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63:11-30.
2. Anderson KE, Mack TM, Silverman DT (2006) Cancer of the pancreas. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention. 3rd ed. New York, NY: Oxford University Press:721-762.
3. Benz C, Hollander C, Miller B (1986) Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines. Cancer Res 46:2276-2281. (Pubitemid 16120681)
4. Bourhis J, Lacaine F, Augusti M, Huguier M (1987) Protective effect of oestrogen in pancreatic cancer. Lancet 2:977. (Pubitemid 17150316)
5. Dahabreh IJ, Trikalinos TA, Paulus JK (2012) Parity and risk of lung cancer in women: systematic review and meta-analysis of epidemiological studies. Lung Cancer 76:150-158.
6. Duell EJ, Travier N, Lujan-Barroso L, Dossus L, Boutron-Ruault MC, et al. (2013) Menstrual and reproductive factors in women, genetic variation in CYP17A1, and pancreatic cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort. Int J Cancer 132:2164-2175.
7. Lee E, Horn-Ross PL, Rull RP, Neuhausen SL, Anton-Culver H, et al. (2013) Reproductive Factors, Exogenous Hormones, and Pancreatic Cancer Risk in the CTS. Am J Epidemiol 178:1403-1413.
8. Lucenteforte E, Zucchetto A, Bosetti C, Talamini R, Negri E, et al. (2011) Reproductive and hormonal factors and pancreatic cancer risk in women. Pancreas 40:460-463.
9. Chang CC, Chiu HF, Yang CY (2010) Parity, age at first birth, and risk of death from pancreatic cancer: evidence from a cohort in Taiwan. Pancreas 39:567-571.
10. Zhang Y, Coogan PF, Palmer JR, Strom BL, Rosenberg L (2010) A case-control study of reproductive factors, female hormone use, and risk of pancreatic cancer. Cancer Causes Control 21:473-478.
11. Duell EJ, Maisonneuve P, Baghurst PA, Bueno-de-Mesquita HB, Ghadirian P, et al. (2009) Menstrual and reproductive factors and pancreatic cancer in the SEARCH program of the IARC. Cancer Causes Control 20:1757-1762.
12. Stevens RJ, Roddam AW, Green J, Pirie K, Bull D, et al. (2009) Reproductive history and pancreatic cancer incidence and mortality in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 18:1457-1460.
13. Heuch I, Jacobsen BK, Albrektsen G, Kvale G (2008) Reproductive factors and pancreatic cancer risk: a Norwegian cohort study. Br J Cancer 98:189-193.
14. Lo AC, Soliman AS, El-Ghawalby N, Abdel-Wahab M, Fathy O, et al. (2007) Lifestyle, occupational, and reproductive factors in relation to pancreatic cancer risk. Pancreas 35:120-129. (Pubitemid 47075565)
15. Prizment AE, Anderson KE, Hong CP, Folsom AR (2007) Pancreatic cancer incidence in relation to female reproductive factors: Iowa Women's Health Study. JOP 8:16-27. (Pubitemid 46157764)
16. Lin Y, Kikuchi S, Tamakoshi A, Kawamura T, Inaba Y, et al. (2006) Association of menstrual and reproductive factors with pancreatic cancer risk in women: findings of the Japan Collaborative Cohort Study for Evaluation of Cancer Risk. J Gastroenterol 41:878-883. (Pubitemid 44594229)
17. Teras LR, Patel AV, Rodriguez C, Thun MJ, Calle EE (2005) Parity, other reproductive factors, and risk of pancreatic cancer mortality in a large cohort of U.S. women (United States). Cancer Causes Control 16:1035-1040. (Pubitemid 41356000)
18. Navarro SS, Miller AB, Rohan TE (2005) Hormonal and reproductive factors and pancreatic cancer risk: a prospective cohort study. Pancreas 30:369-374. (Pubitemid 40586818)
19. Duell EJ, Holly EA (2005) Reproductive and menstrual risk factors for pancreatic cancer: a population-based study of San Francisco Bay Area women. Am J Epidemiol 161:741-747.
20. Skinner HG, Michaud DS, Colditz GA, Giovannucci EL, Stampfer MJ, et al. (2003) Parity, reproductive factors, and the risk of pancreatic cancer in women. Cancer Epidemiol Biomarkers Prev 12:433-438. (Pubitemid 36578481)
21. Kreiger N, Lacroix J, Sloan M (2001) Hormonal factors and pancreatic cancer in women. Ann Epidemiol 11:563-567. (Pubitemid 33049891)
22. Hanley AJ, Johnson KC, Villeneuve PJ, Mao Y (2001) Physical activity, anthropometric factors and risk of pancreatic cancer: results from the Canadian enhanced cancer surveillance system. Int J Cancer 94:140-147. (Pubitemid 32801763)
23. Karlson BM, Wuu J, Hsieh CC, Lambe M, Ekbom A (1998) Parity and the risk of pancreatic cancer: a nested case-control study. Int J Cancer 77:224-227. (Pubitemid 28287974)
24. Ji BT, Hatch MC, Chow WH, McLaughlin JK, Dai Q, et al. (1996) Anthropometric and reproductive factors and the risk of pancreatic cancer: a case-control study in Shanghai, China. Int J Cancer 66:432-437. (Pubitemid 26178166)
25. Fernandez E, La Vecchia C, D'Avanzo B, Negri E (1995) Menstrual and reproductive factors and pancreatic cancer risk in women. Int J Cancer 62:11-14.
26. Kvale G, Heuch I, Nilssen S (1994) Parity in relation to mortality and cancer incidence: a prospective study of Norwegian women. Int J Epidemiol 23:691-699. (Pubitemid 24260367)
27. Cantor KP, Lynch CF, Johnson D (1993) Reproductive factors and risk of brain, colon, and other malignancies in Iowa (United States). Cancer Causes Control 4:505-511. (Pubitemid 24065288)
28. Kalapothaki V, Tzonou A, Hsieh CC, Toupadaki N, Karakatsani A, et al. (1993) Tobacco, ethanol, coffee, pancreatitis, diabetes mellitus, and cholelithiasis as risk factors for pancreatic carcinoma. Cancer Causes Control 4:375-382. (Pubitemid 23205749)
29. La Vecchia C, Negri E, Franceschi S, Parazzini F (1993) Long-term impact of reproductive factors on cancer risk. Int J Cancer 53:215-219. (Pubitemid 23042868)
30. Bueno DMH, Maisonneuve P, Moerman CJ, Walker AM (1992) Anthropometric and reproductive variables and exocrine carcinoma of the pancreas: a population-based case-control study in The Netherlands. Int J Cancer 52:24-29.
31. Haines AP, Moss AR, Whittemore A, Quivey J (1982) A case-control study of pancreatic carcinoma. J Cancer Res Clin Oncol 103:93-97. (Pubitemid 12132319)
32. Miller AB, Barclay TH, Choi NW, Grace MG, Wall C, et al. (1980) A study of cancer, parity and age at first pregnancy. J Chronic Dis 33:595-605. (Pubitemid 10003337)
33. Wahi MM, Shah N, Schrock CE, Rosemurgy AN, Goldin SB (2009) Reproductive factors and risk of pancreatic cancer in women: a review of the literature. Ann Epidemiol 19:103-111.
34. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535.
35. Wu QJ, Xie L, Zheng W, Vogtmann E, Li HL, et al. (2013) Cruciferous vegetables consumption and the risk of female lung cancer: a prospective study and a meta-analysis. Ann Oncol 24:1918-1924.
36. Guan HB, Wu QJ, Gong TT (2013) Parity and kidney cancer risk: evidence from epidemiologic studies. Cancer Epidemiol Biomarkers Prev 22:2345-2353.
37. Hamling J, Lee P, Weitkunat R, Ambuhl M (2008) Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med 27:954-970. (Pubitemid 351395458)
38. Greenland S, Longnecker MP (1992) Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135:1301-1309.
39. Royston P (2000) A strategy for modelling the effect of a continuous covariate in medicine and epidemiology. Stat Med 19:1831-1847.
40. Bagnardi V, Zambon A, Quatto P, Corrao G (2004) Flexible meta-regression functions for modeling aggregate dose-response data, with an application to alcohol and mortality. Am J Epidemiol 159:1077-1086.
41. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558. (Pubitemid 34746062)
42. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188. (Pubitemid 17189972)
43. Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634. (Pubitemid 27387172)
44. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101.
45. La Vecchia C, Negri E, Franceschi S, Parazzini F (1993) Long-term impact of reproductive factors on cancer risk. Int J Cancer 53:215-219. (Pubitemid 23042868)
46. Lindblad P, Mellemgaard A, Schlehofer B, Adami HO, McCredie M, et al. (1995) International renal-cell cancer study. V. Reproductive factors, gynecologic operations and exogenous hormones. Int J Cancer 61:192-198.
47. Longnecker DS, Sumi C (1990) Effects of sex steroid hormones on pancreatic cancer in the rat. Int J Pancreatol 7:159-165.
48. Yen SS (1994) Endocrinology of pregnancy. In: Creasy RK, Resnik R, eds. Maternal-Fetal Medicine: Principles and Practice. 3rd ed. Philadelphia, PA: Saunders:382-412.
49. Sumi C, Longnecker DS, Roebuck BD, Brinck-Johnsen T (1989) Inhibitory effects of estrogen and castration on the early stage of pancreatic carcinogenesis in Fischer rats treated with azaserine. Cancer Res 49:2332-2336. (Pubitemid 19125557)
50. Sumi C, Brinck-Johnsen T, Longnecker DS (1989) Inhibition of a transplantable pancreatic carcinoma by castration and estradiol administration in rats. Cancer Res 49:6687-6692. (Pubitemid 20008809)
51. Iqbal MJ, Greenway B, Wilkinson ML, Johnson PJ, Williams R (1983) Sex-steroid enzymes, aromatase and 5 alpha-reductase in the pancreas: a comparison of normal adult, foetal and malignant tissue. Clin Sci (Lond) 65:71-75. (Pubitemid 13088177)
52. Andren-Sandberg A, Hoem D, Backman PL (1999) Other risk factors for pancreatic cancer: hormonal aspects. Ann Oncol 10 Suppl 4:131-135.
53. Greenway B, Iqbal MJ, Johnson PJ, Williams R (1981) Oestrogen receptor proteins in malignant and fetal pancreas. Br Med J (Clin Res Ed) 283:751-753. (Pubitemid 11050953)
54. Singh S, Baker PR, Poulsom R, Wright NA, Sheppard MC, et al. (1997) Expression of oestrogen receptor and oestrogen-inducible genes in pancreatic cancer. Br J Surg 84:1085-1089. (Pubitemid 27359479)
55. LeRoith D, Roberts CJ (2003) The insulin-like growth factor system and cancer. Cancer Lett 195:127-137. (Pubitemid 36588961)
56. Holmes MD, Pollak MN, Hankinson SE (2002) Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 11:862-867. (Pubitemid 35014889)
57. Jemal A, Clegg LX, Ward E, Ries LA, Wu X, et al. (2004) Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 101:3-27. (Pubitemid 38812419)
58. Rosenberg L, Palmer JR, Wise LA, Horton NJ, Kumanyika SK, et al. (2003) A prospective study of the effect of childbearing on weight gain in African-American women. Obes Res 11:1526-1535. (Pubitemid 41127338)
59. Williamson DF, Madans J, Pamuk E, Flegal KM, Kendrick JS, et al. (1994) A prospective study of childbearing and 10-year weight gain in US white women 25 to 45 years of age. Int J Obes Relat Metab Disord 18:561-569. (Pubitemid 24237585)
60. Kritz-Silverstein D, Barrett-Connor E, Wingard DL (1989) The effect of parity on the later development of non-insulin-dependent diabetes mellitus or impaired glucose tolerance. N Engl J Med 321:1214-1219. (Pubitemid 19273030)
61. Nicholson WK, Asao K, Brancati F, Coresh J, Pankow JS, et al. (2006) Parity and risk of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes Care 29:2349-2354. (Pubitemid 44920109)
62. Il'Yasova D, Hertz-Picciotto I, Peters U, Berlin JA, Poole C (2005) Choice of exposure scores for categorical regression in meta-analysis: a case study of a common problem. Cancer Causes Control 16:383-388.
63. Greenland S (1994) Invited commentary: a critical look at some popular meta-analytic methods. Am J Epidemiol 140:290-296.
64. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: http://www.ohri.ca/programs/clinical- epidemiology/oxford.asp. Accessed October 1, 2013.
65. Luan NN, Wu QJ, Gong TT, Vogtmann E, Wang YL, et al. (2013) Breastfeeding and ovarian cancer risk: a meta-analysis of epidemiologic studies. Am J Clin Nutr 98:1020-1031.